Background/Aims: Tissue degradation in corneal thinning disorders, such as
INTRODUCTION
Keratoconus (KC) is a primary corneal ectasia, generally bilateral and progressive, with a conical shape as a result of the thinning of the stroma. This thinning induces irregular astigmatism, leading to mild to marked impairment in the quality of vision. [1] KC has its onset at puberty, and it progresses until the third or fourth decade of life. [2] In most cases, KC initially affects only one eye. As ectasia develops, it may remain restricted to one eye, but more frequently progresses to both. The second eye may develop KC or remain in an unchanging state referred to as the "forme fruste" or subclinical KC. [3] Currently, reported frequencies of unilateral KC, as determined by using computerized videokeratography techniques, range from 0.5% to 4%. [4, 5] In a recent study, in which 85 unilateral KC patients were monitored over a long period (6 months to 8 years), authors have found that (35.3%) of initially healthy eyes, developed KC during the follow-up period, and (83.3%) of these developed KC within the first 6 years after the initial KC diagnosis. Likewise, the risk of KC onset in initially healthy eyes was higher for those with greater inferior-superior asymmetry (I-S asymmetry). Authors have estimated that over a 16-year period follow-up, about 50% of initially healthy contralateral eyes will develop KC. [6] Unilateral KC can be studied to provide insight into the pathogenesis of the disease. In fact, given that KC may arise without biomicroscopic signs, examination of the initially healthy eye may be useful for the detection of subclinical changes and progression of the disease. [7] There is increasing evidence that supports the fact that KC is an inherited genetic disorder. If this were the case, it would be expected to express itself as a binocular condition, even though variable expression of the gene may show differing levels for each eye. The videokeratoscopy has shown almost every case of apparent monocular KC to be different expressions of the condition in the two eyes. [8] Videokeratoscopes enable the detection of small changes in the corneal topography, which is esential for the detection and monitoring of KC. [9, 10] Orbscan II, that uses a slit scanning procedure to map the anterior and posterior corneal surface, may help to identify frustrated or subclinical forms of KC in a short time. [11] The cornea is part of an integrated system -the ocular surface -which contains specific and non-specific immune molecules. Tissue degradation in thinning disorders, such as keratoconus, involves the expression of inflammatory mediators, such as proinflammatory cytokines, cell adhesion molecules and matrix metalloproteinases. [12] [13] [14] [15] . Moreover, previous studies from our group have demonstrated that the levels of proinflammatory cytokines [interleukin-6 (IL-6) and the tumor necrosis factor alpha (TNF-α)] and matrix metalloproteinase-9 (MMP-9) are significantly increased in the tears of patients with KC. [16] The purpose of this study was to measure levels of proinflammatory cytokines (IL-6 and TNF-α) and MMP-9 in the tears of both eyes from asymmetric KC patients, and to analyze the possible difference between subclinical and KC eyes and normal controls, with a view to contribute to our understanding of whether inflammatory molecules may enhance the progression to KC.
MATERIALS AND METHODS

Patients
We have designed a prospective, cross sectional study in which 30 asymmetric KC patients (30 KC and 30 subclinical KC eyes) and 20 control subjects ( 1 eye) were enrolled. Asymmetric KC patients (70% male; mean age, 27.1 ± 8.1 years) were selected from a database of 385 KC patients at the Instituto Galego de Oftalmoloxía, Santiago de Compostela, Spain, which makes up 7.8% of the sample. We studied both eyes from each patient. Fourteen patients wore rigid gas-permeable (RGP) contact lenses in the keratoconic eye. In addition, 3 of them wore a hydrogel contact lens in the fellow eye. Patients were asked not to wear their contact lenses for a week prior to the study. Controls (47.8% male; mean age, 22.6 ± 6.6 years) were myopic subjects who requested contact lenses, without previous history of keratoconus or eye rubbing, who presented normal topographic patterns. All patients were expressly cited for the purposes of this study, and all examinations were performed by the same researcher 
Instrumental
Basic examination instruments were a Topcon biomicroscope, Topcon refraction column, and alphabetic Snellen visual acuity test. As specific examination instruments we used an EyeSys Corneal System (EyeSys Laboratories, Texas, USA), and an Orbscan II corneal topographer (Orbtek, Utah, USA).
Procedure
Our protocol collected the following information: elapsed time from diagnosis of KC in the first eye, laterality, itching and rubbing, family history of KC and allergies.
After obtaining the best correction, the biomicroscopy exam was performed to detect signs of KC. The corneal topography study was performed using the EyeSys and the Orbscan topographers. Five quantitative topographic parameters were analyzed: simulated keratometry (K) readings, 3 mm irregularity, 5 mm irregularity, posterior elevation and the thinnest point pachymetry of the cornea.
Tear analysis
Tear samples were obtained by capillary flow as previously described. 
RESULTS
Clinical Features
No age-related or sex-related statistical differences were detected between the groups.
The elapsed time from the first diagnosis of KC eye ranged from 1 to 16 years (mean, 5.6 ± 4.3 years). In 22 patients (73.3%) the KC eye was the right one. A family history of KC was reported for 8 patients (26.6%). Eighteen KC patients (60%) reported allergy disease and 15 (50%) a family history of allergy (most commonly to pollen or acaroids).
Nineteen patients (63.3%) reported itchy eyes and, in 69% of them itchiness was more marked in the KC eye. For patients who reported itchy eyes, 58% admitted frequent and vigorous eye rubbing on the KC eye. Three subjects (15%) from the control group reported allergic disease, and no eye rubbing. Table 1 shows the quantitative topographic parameters in KC, subclinical KC and control subjects. Values are expressed in mean (± SD)
Inflammatory mediators
Levels of inflammatory molecules in KC, subclinical KC and controls tears are shown in Table 2 . (Figure 1) .
Association between levels of MMP-9 and the thinnest point pachymetry of the cornea in KC and subclinical KC eyes was also analyzed. As indicated in Placido disk methods, it may be difficult to detect any changes in the anterior corneal face of the contralateral eye. However, Orbscan reveal a raised posterior face and pachymetry, indicative of incipient KC. Binder has also reported KC cases in which topographic changes in the contralateral eyes were observed after LASIK surgery, suggesting that these cases are in fact bilateral KC with marked asymmetry, instead of true asymmetric KC. [18] It likely seems that in most cases, unilateral KC exists only in the early stages of disease, and that in such cases, asymmetry is simply due to unevenness in disease development. In order to try to corroborate the hypothesis that KC is bilateral in last stage, we performed this study about inflammation molecules from tears, which were previously shown to be elevated in KC patients, with the aim of analyze whether inflammatory molecules may enhance the progression of Keratoconus. [16] It seems becoming clear that mediators of inflammation are present in the keratoconus cornea. [14, 19] The presence of collagen degradation products has been reported in the tears of keratoconus patients. [20] In the present study, we demonstrate that the levels of studied cytokines (IL-6 and TNF-α) are significantly increased in the tears from both eyes of patients with asymmetric keratoconus. To our knowledge, this is the first study supporting an important increase of proinflammatory markers in the tear film of subclinical keratoconus eyes. However, MMP-9 levels in tears from subclinical KC eyes are not raised, presenting MMP-9 levels similar to those of control eyes.
Preocular tear film contains numerous specific and non-specific immune components, that include cytokines and cell adhesion molecules. [21, 22] Increased levels of these molecules may be a consequence of increased secretion from the corneal epithelium or from another non-corneal cell type. Various cell types, including keratocytes, produce IL-6 in response to stimulation by IL-1 or TNF-α. [23] In recent years, numerous clinical studies of keratoconus support the idea that its pathogenesis involves an inflammatory component. A variety of changes in the ocular surface of keratoconus patients have been found, including reduced corneal sensitivity, increased fluorescein and rose Bengal staining scores, and abnormal impression cytology such as squamous metaplasia and lower globet cell density. [24] In the same way, increased enzymatic activity has been demonstrated in the conjunctiva of keratoconus patients. [25] Overall, it cannot be ruled out that keratoconus originates in events which take place outside the cornea but which are ultimately responsible for the induction of its ectasia.
Association between keratoconus and allergy, [26] as well as the role played by eye rubbing in the development of ectasia are well established. Eye rubbing may well contribute to the development of keratoconus by activating inflammatory mediators.
The tear may be a vehicle of some of the pathogenic protagonists of keratoconus, such as IL-6, TNF-α or MMP-9. Our results indicate that the concentration of inflammatory molecules in tears is associated with both eyes from asymmetric KC patients, although TNF-α is significantly higher in the KC eye, respect to the subclinical one. This difference could explain the differences in progression for both eyes, since IL-1β and TNF-α have been shown to up-regulate MMP-9 expression in human corneal epithelial cells. [27] Nevertheless, the presence of different classes of enzymes which play a role in the pathological process is not necessarily accompanied by an immediate presentation of corresponding clinical manifestations. [21] We must also bear in mind that there is the possibility that the changes in these inflammatory mediators may be an epiphenomenon of change in corneal structure. It is likely that keratoconus is a disease with a multivariable origin, in which corneal ectasia results from the degradation of stromal collagen.
Thinning and ectasia of the cornea are suggestive of a degraded extracellular matrix. It has become clear that inflammatory events take place in keratoconus and that KC is a bilateral disease that needs inflammatory conditions to progress along the time. The present study reveals that the increase levels of MMP-9 are associated with the corneal thinning; being the minimal corneal thickness related with increases values of MMP-9 in the clinical KC eye. In light of the present results, we believe that when the KC eye diagnosis is achieved for a patient, especially for young people, there is a risk of progression of this disease.
In conclusion, this study reveals that some cytokines such as IL-6 and TNF-α are overexpressed in the tears of subclinical and Kc eyes in patients diagnosed with unilateral KC. However, the precise role of each of these molecular factors still needs to be defined in further studies. These results indicate that KC cannot be defined as a non-inflammatory disorder and that the pathogenesis of KC progression may involve chronic inflammatory events.
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